Diagnostyka Statistics

Total Valuation

Diagnostyka has a market cap or net worth of PLN 5.11 billion. The enterprise value is 6.19 billion.

Market Cap	5.11B
Enterprise Value	6.19B

Important Dates

The last earnings date was Monday, April 20, 2026.

Earnings Date	Apr 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Diagnostyka has 33.76 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	33.76M
Shares Outstanding	33.76M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	51.42%
Owned by Institutions (%)	26.65%
Float	16.40M

Valuation Ratios

The trailing PE ratio is 20.31 and the forward PE ratio is 15.92. Diagnostyka's PEG ratio is 0.47.

PE Ratio	20.31
Forward PE	15.92
PS Ratio	2.12
PB Ratio	9.33
P/TBV Ratio	n/a
P/FCF Ratio	14.72
P/OCF Ratio	9.26
PEG Ratio	0.47

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.59, with an EV/FCF ratio of 17.83.

EV / Earnings	24.59
EV / Sales	2.57
EV / EBITDA	10.59
EV / EBIT	16.17
EV / FCF	17.83

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.97.

Current Ratio	0.73
Quick Ratio	0.58
Debt / Equity	1.97
Debt / EBITDA	1.85
Debt / FCF	3.11
Interest Coverage	5.56

Financial Efficiency

Return on equity (ROE) is 53.41% and return on invested capital (ROIC) is 20.48%.

Return on Equity (ROE)	53.41%
Return on Assets (ROA)	12.63%
Return on Invested Capital (ROIC)	20.48%
Return on Capital Employed (ROCE)	24.49%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	307,614
Profits Per Employee	32,109
Employee Count	7,836
Asset Turnover	1.27
Inventory Turnover	8.85

Taxes

In the past 12 months, Diagnostyka has paid 55.01 million in taxes.

Income Tax	55.01M
Effective Tax Rate	17.36%

Stock Price Statistics

The stock price has decreased by -0.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-0.46%
50-Day Moving Average	172.01
200-Day Moving Average	182.84
Relative Strength Index (RSI)	35.92
Average Volume (20 Days)	89,357

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diagnostyka had revenue of PLN 2.41 billion and earned 251.60 million in profits. Earnings per share was 7.45.

Revenue	2.41B
Gross Profit	1.91B
Operating Income	382.70M
Pretax Income	316.88M
Net Income	251.60M
EBITDA	584.50M
EBIT	382.70M
Earnings Per Share (EPS)	7.45

Full Income Statement

Balance Sheet

The company has 20.19 million in cash and 1.08 billion in debt, giving a net cash position of -1.06 billion or -31.41 per share.

Cash & Cash Equivalents	20.19M
Total Debt	1.08B
Net Cash	-1.06B
Net Cash Per Share	-31.41
Equity (Book Value)	547.19M
Book Value Per Share	15.65
Working Capital	-138.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 551.77 million and capital expenditures -204.78 million, giving a free cash flow of 346.99 million.

Operating Cash Flow	551.77M
Capital Expenditures	-204.78M
Depreciation & Amortization	201.79M
Net Borrowing	-98.26M
Free Cash Flow	346.99M
FCF Per Share	10.28

Full Cash Flow Statement

Margins

Gross margin is 79.05%, with operating and profit margins of 15.88% and 10.44%.

Gross Margin	79.05%
Operating Margin	15.88%
Pretax Margin	13.15%
Profit Margin	10.44%
EBITDA Margin	24.25%
EBIT Margin	15.88%
FCF Margin	14.40%

Dividends & Yields

This stock pays an annual dividend of 3.31, which amounts to a dividend yield of 2.15%.

Dividend Per Share	3.31
Dividend Yield	2.15%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	44.41%
Buyback Yield	-0.05%
Shareholder Yield	2.11%
Earnings Yield	4.93%
FCF Yield	6.79%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Diagnostyka has an Altman Z-Score of 4.18 and a Piotroski F-Score of 6.

Altman Z-Score	4.18
Piotroski F-Score	6